Capital Flow Monitor · Sponsors · CIK 2131104
Converge Bio Inc.
2093 PHILADELPHIA PIKE #1664, CLAYMONT, DE, 19703 · 6173518116
Biotechnology · Corporation· inc. DELAWARE true 2024
Fit score
—
Offering
$25.0M
Sold
$25.0M
% sold
100.0%
Investors
19
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-28 | D ·current | 506(b) | $25.0M | $25.0M | 100.0% | 19 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Dov Gertz — Executive Officer / Director, Claymont, DE
- Oded Kalev — Executive Officer / Director, Claymont, DE
- Shahar Tzafrir — Director, Claymont, DE
-
Andrew Hedin — Director, Claymont, DE
1 other raise
- Triana Biomedicines, Inc. $120.1M of $120.1M · 100.0%
- Iddo Weiner — Executive Officer, Claymont, DE
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.